Row Labels |
All Patients |
PAF |
PsAF |
PAF versus PsAF |
p value |
|
|
|
|
|
(n=70) |
(n=40) |
(n=30) |
|
Age (SD) |
64.5 ± 8.9 |
64,5 ± 9 |
64 ± 9 |
p= 0.20 |
Male |
47 (67.1%) |
25 (62.5%) |
22 (73.3%) |
|
Hypertension |
58 (82.8%) |
30 (75%) |
28 (93.3%) |
p=
0.04 |
Diabetes |
14 (20%) |
5 (12.5%) |
9 (30%) |
p= 0.07 |
Obese (bmi ≥30) |
18 (25.7%) |
7 (17.5%) |
11(36.7%) |
p=
0.47 |
Overweight (bmi ≥25) |
45 (64.3%) |
28 (70%) |
17 (56.7%) |
p=
0.19 |
CAD |
10 (14.3%) |
6 (60%) |
4 (40%) |
p>0.5 |
Type of AF |
|
40 (57.2%) |
30 (42.8%) |
|
AF duration |
|
|
|
|
≥48 m |
27 (38.6%) |
14 (35%) |
13 (43.3%) |
p= 0.07 |
≤36 m |
40 (57.1%) |
23 (57.5%) |
17 (43.5%) |
p= 0.72 |
LVEF ≥30% |
8 (11.43%) |
4 (50%) |
4 (50%) |
p= 0.07 |
LVEF ≥50% |
62 (88.57%) |
36 (58%) |
26 (42%) |
p=
0.01 |
LA volume(ml/m2) |
|
|
|
|
≥28 |
37 (53%) |
13 (35%) |
24 (65%) |
p<0.0001 |
<28 |
33 (47%) |
27 (82%) |
6 (18%) |
p<0.0001 |